HEAD AND NECK NEOPLASMS

This study is testing a drug called entrectinib for people with advanced solid tumors that have specific genetic changes (NTRK, ROS1, or ALK gene rearrangements). It's a 'basket trial,' meaning it groups patients by their tumor's genetic type rather than where the cancer started …

This early-stage study is testing a new personalized cell therapy called KSQ-001EX in people with advanced melanoma, lung cancer, or head and neck cancer. Doctors take a patient's own immune cells from a tumor, genetically modify them to potentially be more powerful, and then inf…

This study is testing an experimental drug called disitamab vedotin for adults with advanced or metastatic solid tumors that have a specific marker called HER2. The trial includes people with head and neck, lung, ovarian, or endometrial cancers who have already tried other treatm…

This early-stage study is testing whether a mouthwash made from copaiba, a natural resin, is safe and tolerable for patients with oral cancer who are receiving radiotherapy. The main goal is to see if it can help prevent or reduce the severity of oral mucositis—painful mouth sore…

This study compares two standard treatments for early-stage throat cancer to see which better preserves patients' quality of life, especially their ability to swallow. It randomly assigns 138 patients to receive either minimally invasive robotic surgery or targeted radiation ther…

This study aimed to test if a personalized online education program could help patients and their caregivers feel more prepared for major head and neck cancer surgery. It planned to see if the program improved patient satisfaction and reduced the need for unplanned hospital visit…

This study aims to understand what helps head and neck or lung cancer patients stay smoke-free after completing radiation or chemo-radiation treatment. Researchers will follow 100 patients for one year after treatment, checking in at 1, 6, and 12 months to track their smoking sta…